CBD Pet Market (By Animal Type: Dogs, Cats; By Indication: Joint Pain, Anxiety/Stress, General Health/Wellness; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2023-2032

The global CBD pet market was surpassed at USD 196.02 million in 2022 and is expected to hit around USD 3,110.09 million by 2032, growing at a CAGR of 31.84% from 2023 to 2032.

CBD Pet Market Size 2023 to 2032

Key Pointers

  • In 2022, the dogs segment held the largest revenue share by animal type.
  • Cats are the second-most popular choice as pets.Hence, the segment is thus projected to grow the fastest at a rate of over 30.04% from 2023 to 2032.
  • By indication, joint pain accounted for the highest share of over 20.04% of the market in 2022.
  • The anxiety/stress segment on the other hand is estimated to grow at the fastest CAGR of over 31.1%.
  • The e-commerce segment dominated the market with the largest revenue share of more than 42.4% in 2022.
  • The North America region dominated the CBD pet industry in 2022 with a share of over 40.6%.
  • The CBD pet landscape in Asia Pacific is expected to expand the fastest at a rate of over 33.17% during the forecast period.
Report Coverage Details
Market Size in 2022 USD 196.02 million
Revenue Forecast by 2032 USD 3,110.09 million
Growth rate from 2023 to 2032 CAGR of 31.84%
Base Year 2022
Forecast Period 2023 to 2032
Regions Covered North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Covered Honest Paws; Canna-Pet; FOMO Bones; Pet Releaf; HolistaPet; Joy Organics; Wet Noses Natural Dog Treat Co.; CBD Living; PETstock; Petco Animal Supplies, Inc.; Charlotte’s Web; Green Roads; HempMy Pet

 

The market is primarily driven by factors such as rising R&D initiatives, increasing demand, pet humanization, and expenditure. The complexity and uncertainty around regulations, however, is a key restraining factor for the cannabidiol (CBD) pet market. Many CBD companies are thus pursuing certification from veterinary organizations or trusted animal-welfare groups [such as the National Animal Supplement Council (NASC)] to help differentiate their products and assure customers of product quality. In October 2019, Medterra CBD’s line of CBD pet products including tinctures and pet chews gained the NASC approval.

The COVID-19 pandemic had an overall neutral impact on the CBD pet market due to the presence of both positive and negative factors. Restraining factors included supply chain hurdles, operational challenges, complexities in regulations, and a decline in CBD prices. As per an independent survey by LeafReport, CBD prices decreased by 17% in 2020 except for pet edibles, which registered a 44% increase in prices. This was due to the entry of more hemp suppliers in the market since the implementation of the farm bill in 2018.

The positive impact included an increase in demand for CBD pet products owing to rising pet health concerns and pet expenditure. As per the chief marketing officer at cbdMD, Matt Coapman, and Paw CBD, the COVID-19 pandemic propelled CBD sales as people stayed at home and were more attuned to their pet’s health. After the COVID-19 pandemic, as pet parents started to go back to their offices, CBD products gained demand as a means to alleviate any separation issues the pets may have. Anxiety issues (separation, noise aversion, etc.), comfort support, and mobility are the most common reasons pet owners opt for CBD.

CBD or cannabidiol is a plant-based chemical that has a proven therapeutic value for animal companions. Its benefits include pain relief & seizure control. Its anti-inflammatory actions have also been studied. This non-psychoactive compound appears to be safe for use in pets such as dogs and cats. As CBD gains more attention among pet owners, CBD-derived products become more diverse in forms such as treats, foods, oils, topicals, and tinctures. Owing to rising awareness, pet owners are increasingly using CBD for their cats, dogs, and other pets. For instance, according to a survey conducted by Leafreport in 2021, 50% of the respondent pet owners in the U.S., reported using CBD for their pets. Such factors are expected to fuel market growth.

CBD Pet Market Segmentations:

By Animal Type By Indication By Distribution Channel

Dogs

Cats

Others

Joint Pain

Anxiety/Stress

Epilepsy

General Health/Wellness

Other Indications

Pet Specialty Stores

E-commerce

CBD Stores

Others

Frequently Asked Questions

The global CBD pet market size was reached at USD 196.02 million in 2022 and it is projected to hit around USD 3,110.09 million by 2032.

The global CBD pet market is growing at a compound annual growth rate (CAGR) of 31.84% from 2023 to 2032.

The North America region has accounted for the largest CBD pet market share in 2022.

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on CBD Pet Market 

5.1. COVID-19 Landscape: CBD Pet Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global CBD Pet Market, By Animal Type

8.1. CBD Pet Market, by Animal Type, 2023-2032

8.1.1 Dogs

8.1.1.1. Market Revenue and Forecast (2019-2032)

8.1.2. Cats

8.1.2.1. Market Revenue and Forecast (2019-2032)

8.1.3. Others

8.1.3.1. Market Revenue and Forecast (2019-2032)

Chapter 9. Global CBD Pet Market, By Indication

9.1. CBD Pet Market, by Indication, 2023-2032

9.1.1. Joint Pain

9.1.1.1. Market Revenue and Forecast (2019-2032)

9.1.2. Anxiety/Stress

9.1.2.1. Market Revenue and Forecast (2019-2032)

9.1.3. Epilepsy

9.1.3.1. Market Revenue and Forecast (2019-2032)

9.1.4. General Health/Wellness

9.1.4.1. Market Revenue and Forecast (2019-2032)

9.1.5. Other Indications

9.1.5.1. Market Revenue and Forecast (2019-2032)

Chapter 10. Global CBD Pet Market, By Distribution Channel 

10.1. CBD Pet Market, by Distribution Channel, 2023-2032

10.1.1. Pet Specialty Stores

10.1.1.1. Market Revenue and Forecast (2019-2032)

10.1.2. E-commerce

10.1.2.1. Market Revenue and Forecast (2019-2032)

10.1.3. CBD Stores

10.1.3.1. Market Revenue and Forecast (2019-2032)

10.1.4. Others

10.1.4.1. Market Revenue and Forecast (2019-2032)

Chapter 11. Global CBD Pet Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Animal Type (2019-2032)

11.1.2. Market Revenue and Forecast, by Indication (2019-2032)

11.1.3. Market Revenue and Forecast, by Distribution Channel (2019-2032)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Animal Type (2019-2032)

11.1.4.2. Market Revenue and Forecast, by Indication (2019-2032)

11.1.4.3. Market Revenue and Forecast, by Distribution Channel (2019-2032)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Animal Type (2019-2032)

11.1.5.2. Market Revenue and Forecast, by Indication (2019-2032)

11.1.5.3. Market Revenue and Forecast, by Distribution Channel (2019-2032)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Animal Type (2019-2032)

11.2.2. Market Revenue and Forecast, by Indication (2019-2032)

11.2.3. Market Revenue and Forecast, by Distribution Channel (2019-2032)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Animal Type (2019-2032)

11.2.4.2. Market Revenue and Forecast, by Indication (2019-2032)

11.2.4.3. Market Revenue and Forecast, by Distribution Channel (2019-2032)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Animal Type (2019-2032)

11.2.5.2. Market Revenue and Forecast, by Indication (2019-2032)

11.2.5.3. Market Revenue and Forecast, by Distribution Channel (2019-2032)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Animal Type (2019-2032)

11.2.6.2. Market Revenue and Forecast, by Indication (2019-2032)

11.2.6.3. Market Revenue and Forecast, by Distribution Channel (2019-2032)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Animal Type (2019-2032)

11.2.7.2. Market Revenue and Forecast, by Indication (2019-2032)

11.2.7.3. Market Revenue and Forecast, by Distribution Channel (2019-2032)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Animal Type (2019-2032)

11.3.2. Market Revenue and Forecast, by Indication (2019-2032)

11.3.3. Market Revenue and Forecast, by Distribution Channel (2019-2032)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Animal Type (2019-2032)

11.3.4.2. Market Revenue and Forecast, by Indication (2019-2032)

11.3.4.3. Market Revenue and Forecast, by Distribution Channel (2019-2032)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Animal Type (2019-2032)

11.3.5.2. Market Revenue and Forecast, by Indication (2019-2032)

11.3.5.3. Market Revenue and Forecast, by Distribution Channel (2019-2032)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Animal Type (2019-2032)

11.3.6.2. Market Revenue and Forecast, by Indication (2019-2032)

11.3.6.3. Market Revenue and Forecast, by Distribution Channel (2019-2032)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Animal Type (2019-2032)

11.3.7.2. Market Revenue and Forecast, by Indication (2019-2032)

11.3.7.3. Market Revenue and Forecast, by Distribution Channel (2019-2032)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Animal Type (2019-2032)

11.4.2. Market Revenue and Forecast, by Indication (2019-2032)

11.4.3. Market Revenue and Forecast, by Distribution Channel (2019-2032)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Animal Type (2019-2032)

11.4.4.2. Market Revenue and Forecast, by Indication (2019-2032)

11.4.4.3. Market Revenue and Forecast, by Distribution Channel (2019-2032)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Animal Type (2019-2032)

11.4.5.2. Market Revenue and Forecast, by Indication (2019-2032)

11.4.5.3. Market Revenue and Forecast, by Distribution Channel (2019-2032)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Animal Type (2019-2032)

11.4.6.2. Market Revenue and Forecast, by Indication (2019-2032)

11.4.6.3. Market Revenue and Forecast, by Distribution Channel (2019-2032)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Animal Type (2019-2032)

11.4.7.2. Market Revenue and Forecast, by Indication (2019-2032)

11.4.7.3. Market Revenue and Forecast, by Distribution Channel (2019-2032)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Animal Type (2019-2032)

11.5.2. Market Revenue and Forecast, by Indication (2019-2032)

11.5.3. Market Revenue and Forecast, by Distribution Channel (2019-2032)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Animal Type (2019-2032)

11.5.4.2. Market Revenue and Forecast, by Indication (2019-2032)

11.5.4.3. Market Revenue and Forecast, by Distribution Channel (2019-2032)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Animal Type (2019-2032)

11.5.5.2. Market Revenue and Forecast, by Indication (2019-2032)

11.5.5.3. Market Revenue and Forecast, by Distribution Channel (2019-2032)

Chapter 12. Company Profiles

12.1. Honest Paws

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Canna-Pet

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. FOMO Bones

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Pet Releaf

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. HolistaPet

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Joy Organics

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Wet Noses Natural Dog Treat Co.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. CBD Living

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. PETstock

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Petco Animal Supplies, Inc.

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers